← Back to headlines
Lilly's Jaypirca Shows Extended Progression-Free Survival in CLL Treatment
New data for Lilly's drug Jaypirca indicates extended progression-free survival in patients with Chronic Lymphocytic Leukemia, marking a potential advancement in treatment.
13 Apr, 12:13 — 13 Apr, 12:13
Sources
Showing 1 of 1 sources
Related Stories
'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
Study Reveals Early Human Quarrying in South Africa 220,000 Years Ago
1m ago
CSIR Scientist Advocates Community-Driven Approach to Combat Illegal Mining in Ghana
12m ago
Reader's Opinion: English as the Universal Language of Science
20m ago